Is albumin infusion necessary after large volume paracentesis? Pro – main arguments
2009; Wiley; Volume: 29; Issue: 5 Linguagem: Inglês
10.1111/j.1478-3231.2009.02027_1.x
ISSN1478-3231
Autores Tópico(s)Organ Transplantation Techniques and Outcomes
ResumoLiver InternationalVolume 29, Issue 5 p. 636-638 Is albumin infusion necessary after large volume paracentesis? Pro – main arguments Andrés Cárdenas, Andrés Cárdenas GI Unit, Institut de Malalties Digestives i Metaboliques, Hospital Clínic and University of Barcelona, Institut d'Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS), Ciber de Enfermedades Hepáticas y Digestivas (CIBERHED), Barcelona, SpainSearch for more papers by this authorPere Ginès, Pere Ginès Liver Unit, Institut de Malalties Digestives i Metaboliques, Hospital Clínic and University of Barcelona, Institut d'Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS), Ciber de Enfermedades Hepáticas y Digestivas (CIBERHED), Barcelona, SpainSearch for more papers by this author Andrés Cárdenas, Andrés Cárdenas GI Unit, Institut de Malalties Digestives i Metaboliques, Hospital Clínic and University of Barcelona, Institut d'Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS), Ciber de Enfermedades Hepáticas y Digestivas (CIBERHED), Barcelona, SpainSearch for more papers by this authorPere Ginès, Pere Ginès Liver Unit, Institut de Malalties Digestives i Metaboliques, Hospital Clínic and University of Barcelona, Institut d'Investigacions Biomèdiques August Pi-Sunyer (IDIBAPS), Ciber de Enfermedades Hepáticas y Digestivas (CIBERHED), Barcelona, SpainSearch for more papers by this author First published: 07 April 2009 https://doi.org/10.1111/j.1478-3231.2009.02027_1.xCitations: 22 Correspondence Pere Ginès, MD, Liver Unit, Hospital Clinic, Villarroel 170, 08036, Barcelona, SpainTel: 93 227 5753Fax: 93 451 5522e-mail: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Cárdenas A, Ginès P. Mechanisms of ascites formation. In: A Sanyal, V Shah, eds. Portal Hypertension. Humana Press, Totowa, NJ, 2005; 65– 84. 2 Ginès P, Arroyo V, Quintero E, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987; 93: 234– 41. 3 Salerno F, Badalamenti S, Incerti P, et al. Repeated paracentesis and i.v. albumin infusion to treat ‘tense’ ascites in cirrhotic patients: a safe alternative therapy. J Hepatol 1987; 5: 102– 8. 4 Moore KP, Wong F, Ginès P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258– 66. 5 Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut 2006; 55 (Suppl. 6): vi1– 12. 6 Ginès P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94: 1493– 502. 7 Ruiz-del-Arbol L, Monescillo A, Jiménez W, et al. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997; 113: 579– 86. 8 Ginès A, Fernández-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002– 110. 9 Sola-Vera J, Minana J, Ricart E, et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003; 37: 1147– 53. 10 Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41: 1211– 9. 11 Alderson P, Bunn F, Lefebvre C, et al. Albumin reviewers. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev, 8 October 2004;(4):CD001208. 12 Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247– 56. 13 Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 5: 403– 9. 14 Sanyal AJ, Boyer T, Garcia-Tsao G, et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 2008; 134: 1360– 8. 15 Martín-Llahí M, Pépin MN, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 2008; 134: 1352– 9. 16 Stadlbauer V, Mookerjee RP, Wright GA, et al. Albumin and other endotoxin removal methods restore neutrophil function ex vivo in patients with severe alcoholic hepatitis. Hepatology 2007; 46: 204A. 17 Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008; 28: 26– 42. 18 Planas R, Ginès P, Arroyo V, et al. Dextran 70 vs albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 1990; 99: 1736– 44. 19 Salerno F, Badalamenti S, Lorenzano E, et al. Randomized comparative study of Hemaccel vs albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 1991; 13: 707– 13. 20 Fassio E, Terg R, Landeira G, et al. Paracentesis with dextran 70 vs paracentesis with albumin in cirrhosis with tense ascites: results of a randomized study. J Hepatol 1992; 14: 310– 6. 21 Altman C, Bernard B, Roulot D, Vitte RL, Ink O. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis. Eur J Gastroenterol Hepatol 1998; 10: 5– 10. 22 Garcιa-Compean D, Zacarιas Villarreal J, Bahena Cuevas H, et al. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites. Liver 1993; 13: 233– 8. 23 Wong CL, Holroyd-Leduc J, Thorpe KE, Straus SE. Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? JAMA 2008; 299: 1166– 78. 24 Runyon B. Management of adult patients with ascites due to cirrhosis. Hepatology 2004; 39: 841– 56. Citing Literature Volume29, Issue5May 2009Pages 636-638 ReferencesRelatedInformation
Referência(s)